Dechra Pharm PLC
17 March 2008
BLOCKLISTING SIX MONTHLY RETURN
INFORMATION PROVIDED ON THIS FORM MUST BE TYPED OR PRINTED ELECTRONICALLY
AND PROVIDED TO AN RIS.
Date: 14 March 2008
Name of applicant: Dechra Pharmaceuticals PLC
Name of scheme Approved Share Option Scheme
Period of return: From 15 September 2007 To 14 March 2008
Balance of unallotted securities under scheme(s) from previous return:
48,000
Plus: The amount by which the block scheme(s) has been increased since the
date of the last return (if any increase has been applied for):
222,000
Less: Number of securities issued/allotted under scheme(s) during period
(see LR3.5.7G):
16,333
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
253,667
Name of contact Zoe Bamford
Telephone number of contact 01782 771100
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.